An APE1-CRISPR/Cas12a cascaded amplification platform for breast cancer-related microRNA analysis
New Journal of Chemistry · 2026 · 50 (30) · 12648-12654
DOI: 10.1039/d6nj01779g ↗Kurz gefasst
Fachartikel in der Zeitschrift New Journal of Chemistry, 2026. Verfasst von Ruixuan Zhou und 5 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
An APE1-CRISPR/Cas12a cascaded platform achieves a detection limit of 4.5 fM for miRNA, and demonstrates robust diagnostic accuracy in breast cancer patient plasma with an AUC of 0.92.
Zitieren
APA
Zhou, R., Wei, Y., Liu, X., Lei, X., Ren, Y., & Ying, K. (2026). An APE1-CRISPR/Cas12a cascaded amplification platform for breast cancer-related microRNA analysis. New Journal of Chemistry, 50(30), 12648-12654. https://doi.org/10.1039/d6nj01779g
Vancouver
Zhou R, Wei Y, Liu X, Lei X, Ren Y, Ying K. An APE1-CRISPR/Cas12a cascaded amplification platform for breast cancer-related microRNA analysis. New Journal of Chemistry. 2026;50(30):12648-12654. doi:10.1039/d6nj01779g
BibTeX
@article{Zhou2026,
author = {Zhou, Ruixuan and Wei, Ying and Liu, Xingxing and Lei, Xiaoyun and Ren, Yongan and Ying, Keming},
title = {An APE1-CRISPR/Cas12a cascaded amplification platform for breast cancer-related microRNA analysis},
journal = {New Journal of Chemistry},
year = {2026},
volume = {50},
number = {30},
pages = {12648--12654},
doi = {10.1039/d6nj01779g}
}
EUVIMED